๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A spectrum of pulmonary vascular pathology in portopulmonary hypertension

โœ Scribed by Michael J. Krowka; William D. Edwards

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
205 KB
Volume
6
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Assessment of acute pulmonary vascular r
Assessment of acute pulmonary vascular reactivity in portopulmonary hypertension
โœ Giovanni L. Ricci; Maria Teresa Melgosa; Felip Burgos; Josรฉ Luis Valera; Sandra ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 211 KB

The role of acute pulmonary vasodilator testing in portopulmonary hypertension (PoPH), a current contraindication for orthotopic liver transplantation (OLT), has not been thoroughly elucidated. The purpose of this work was to analyze the results of acute vasodilator testing with inhaled nitric oxide

Inhaled nitric oxide reduces pulmonary a
Inhaled nitric oxide reduces pulmonary artery pressures in portopulmonary hypertension
โœ Findlay, James Y. ;Harrison, Barry A. ;Plevak, David J. ;Krowka, Michael J. ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 85 KB

## Pulmonary artery hypertension in association with liver failure (portopulmonary hypertension [PPHTN] ) is a significant barrier to liver transplantation because patients with this condition have a very high mortality when transplantation is undertaken. Inhaled nitric oxide (NO), a potent pulmon

Improvement in pulmonary hemodynamics du
Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension
โœ Michael J. Krowka; Robert P. Frantz; Michael D. McGoon; Cathy Severson; David J. ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 125 KB

Pulmonary hypertension associated with increased pulmonary vascular resistance (PVR) and occurring in the setting of portal hypertension is referred to as ''portopulmonary hypertension.'' Intravenous epoprostenol (prostacyclin) is a potent pulmonary and systemic vasodilator with antithrombotic prope